ProKidney Corp’s Market Journey: Closing Weak at 0.67, Down -7.50

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

The closing price of ProKidney Corp (NASDAQ: PROK) was $0.67 for the day, down -7.50% from the previous closing price of $0.72. In other words, the price has decreased by -$7.50 from its previous closing price. On the day, 12.35 million shares were traded. PROK stock price reached its highest trading level at $0.7421 during the session, while it also had its lowest trading level at $0.6687.

Ratios:

Our analysis of PROK’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.96 and its Current Ratio is at 10.96.

On September 10, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $6.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 22 ’25 when Control Empresarial de Capital bought 387,393 shares for $0.71 per share. The transaction valued at 276,366 led to the insider holds 73,842,723 shares of the business.

Control Empresarial de Capital bought 25,000 shares of PROK for $18,690 on Apr 17 ’25. The Add’l Rep. Persons-see Ex.99-1 now owns 73,455,330 shares after completing the transaction at $0.75 per share. On Apr 16 ’25, another insider, Control Empresarial de Capital, who serves as the Add’l Rep. Persons-see Ex.99-1 of the company, bought 100,000 shares for $0.75 each. As a result, the insider paid 74,820 and bolstered with 73,430,330 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PROK now has a Market Capitalization of 1758186112 and an Enterprise Value of 1130021760. For the stock, the TTM Price-to-Sale (P/S) ratio is 631.39. Its current Enterprise Value per Revenue stands at 3692.882 whereas that against EBITDA is -6.504.

Stock Price History:

The Beta on a monthly basis for PROK is 1.45, which has changed by -0.7324 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, PROK has reached a high of $2.59, while it has fallen to a 52-week low of $0.46. The 50-Day Moving Average of the stock is -16.87%, while the 200-Day Moving Average is calculated to be -52.27%.

Shares Statistics:

PROK traded an average of 950.88K shares per day over the past three months and 2544500 shares per day over the past ten days. A total of 129.54M shares are outstanding, with a floating share count of 94.19M. Insiders hold about 27.29% of the company’s shares, while institutions hold 41.69% stake in the company. Shares short for PROK as of 1749772800 were 16799156 with a Short Ratio of 17.67, compared to 1747267200 on 15942724. Therefore, it implies a Short% of Shares Outstanding of 16799156 and a Short% of Float of 18.490000000000002.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.